维吾尔族玻璃体注射曲安耐德治疗缺血型视网膜中央静脉阻塞性黄斑水肿的观察

Observation on vitreous body injected by triamcinolone in the treatment of Uygur patients with ischemic central retinal vein occlusion macular edema

目的:观察玻璃体注射曲安耐德(IVTA)治疗维吾尔族缺血型视网膜中央静脉阻塞性黄斑水肿的临床疗效。方法:收治维吾尔族缺血型视网膜中央静脉阻塞引起的黄斑水肿患者60例,平分为试验组和对照组,均给予改善微循环治疗,试验组加用IVTA治疗,观察两组疗效。结果:试验组治疗后1个月、3个月、6个月的BVCA值均显著高于对照组;黄斑中心凹厚度值均显著小于对照组;试验组治疗后的静脉迂张改善,黄斑水肿、视盘水肿改善率均明显高于对照组,并发症发生率显著低于对照组,差异均具有统计学意义(P<0.05)。结论:IVTA治疗缺血型视网膜中央静脉阻塞性黄斑水肿,可以明显改善黄斑水肿、视盘水肿,缓解视网膜缺血状态,改善视功能,疗效确切。

Objective:To observe the effect of vitreous body injected by triamcinolone in the treatment of Uygur patients with ischemic central retinal vein occlusion macular edema.Methods:60 Uygur patients with ischemic central retinal vein occlusion macular edema were selected.They were divided into the experimental group and the control group.All patients were treated with improved microcirculation.On this basis,the experimental group was treated with IVTA.Results:The BVCA value of the experimental group was significantly higher than that of the control group at 1 month,3 months,6 months after treatment.The thickness values of the central retinal thickness was significantly lower than that in the control group.The improvement rate of circuitous vein,macular edema,papilloedema in the experimental group after treatment were significantly higher than those in the control group,the incidence of complications was significantly lower than that of the control group.The differences were statistically significant(P < 0.05).Conclusion:IVTA in the treatment of patients with ischemic central retinal vein occlusion macular edema can significantly improve the macular edema and papilloedema,relieve retinal ischemic state,improve the visual function.The curative effect is obvious.